Class 2 medicines recall: Nacrez 75 microgram Film-coated Tablets (Desogestrel) PL 00289/1706

Action Within 48 Hours. Wholesaler and Pharmacy Level Recall. Teva UK Limited is recalling batches due to out of specification results for impurities obtained during routine stability testing.

Product information

EL number

EL (16)A/14

MDR number

MDR 37-08/16

Company name

Teva UK Limited

Product description

Batch Number Expiry Date Pack Size First distributed
N47810 31/01/2017 84 (3 x 28) Apr-14
N47811 31/01/2017 84 (3 x 28) Jun-14
N47812 31/01/2017 84 (3 x 28) Jun-14
N47813 31/01/2017 84 (3 x 28) Jul-14
N47815 31/01/2017 84 (3 x 28) Dec-14
N47816 31/01/2017 84 (3 x 28) Jan-15
N47823 30/04/2017 84 (3 x 28) Jul-15
N47824 30/04/2017 84 (3 x 28) May-15
O19870 31/10/2017 84 (3 x 28) Oct-15
O19871 31/10/2017 84 (3 x 28) Sep-15
R35105 30/06/2018 84 (3 x 28) Mar-16
R35106 30/06/2018 84 (3 x 28) Apr-16

Brief description of the problem

Teva UK Limited is recalling the above batches because out of specification results for impurities were obtained during routine stability testing. No complaints relating to this issue have been received by the company to date.

Women currently using this product are advised to finish the pack and if they have any concerns they should speak to their doctor or pharmacist.

Remaining stock of these batches should be quarantined and returned to the original supplier for credit.

For stock enquiries, please contact Teva UK Limited Customer Service on 0800 590 502.

For medical information enquiries please contact Teva UK Limited by phone on 0207 5407117 or by email to medinfo@teva.com.

Download document

Nacrez 75 microgram Film-coated Tablets - Desogestrel - class 2 medicines recall

Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. NHS Regional teams: please cascade to relevant clinics, general practitioners and community pharmacists.

Updates to this page

Published 19 October 2016